Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
LBA5 Primary results of the phase III KEYNOTE-412 study: Pembrolizumab (pembro) with chemoradiation therapy (CRT) vs placebo plus CRT for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)
J-P. Machiels, Yungan Tao, Barbara Ann Burtness, M. Tahara, D. Rischin, G.V. Alves and 14 more
- Rank
- 52 of 3,616
- Percentile
- top 1.5%
- Where
- Annals of Oncology, 2022
- Citations
- 96
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.